Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyeon Park

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Diabetes, Obesity & Metabolism|July 16, 2025
Adherence to GLP-1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among Medicare beneficiaries with diabetesNicklas S Klepser, Ellerie S Weber, Lihua Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 9, 2013
Urine stability studies for novel biomarkers of acute kidney injuryChirag R Parikh, Isabel Butrymowicz, Angela Yu, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
ADPKD-Causing Missense Variants in Polycystin-1 Disrupt Cell Surface Localization or Polycystin Channel FunctionKotdaji Ha, Gabriel B Loeb, Meyeon Park, et al.
Kidney360|September 30, 2022
Design and Basic Characteristics of a National Patient-Powered Registry in ADPKDElise Hoover, Ronald D Perrone, Chris Rusconi, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2015
Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation TrialNisha Bansal, Myra A Carpenter, Daniel E Weiner, et al.
Journal of the American Society of Nephrology : JASN|September 1, 2012
Associations between kidney function and subclinical cardiac abnormalities in CKDMeyeon Park, Chi-yuan Hsu, Yongmei Li, et al.
Diabetes Care|May 23, 2023
Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regressionJosé M Rodriguez-Valadez, Malak Tahsin, Kirsten E Fleischmann, et al.
Journal of the American Heart Association|February 16, 2024
Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta-Regression AnalysisJosé M Rodriguez-Valadez, Malak Tahsin, Umesh Masharani, et al.
BMC Nephrology|August 18, 2019
Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patientsMats C H Lassen, Atif N Qasim, Tor Biering-Sørensen, et al.
JAMA Internal Medicine|June 22, 2026
Apolipoprotein L1 Gene Genotype and Kidney Outcomes After Living Kidney DonationChi-Yuan Hsu, Ying Gao, Barry I Freedman, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|July 16, 2025
Adherence to GLP-1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among Medicare beneficiaries with diabetesNicklas S Klepser, Ellerie S Weber, Lihua Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 9, 2013
Urine stability studies for novel biomarkers of acute kidney injuryChirag R Parikh, Isabel Butrymowicz, Angela Yu, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
ADPKD-Causing Missense Variants in Polycystin-1 Disrupt Cell Surface Localization or Polycystin Channel FunctionKotdaji Ha, Gabriel B Loeb, Meyeon Park, et al.
Kidney360|September 30, 2022
Design and Basic Characteristics of a National Patient-Powered Registry in ADPKDElise Hoover, Ronald D Perrone, Chris Rusconi, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2015
Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation TrialNisha Bansal, Myra A Carpenter, Daniel E Weiner, et al.
Journal of the American Society of Nephrology : JASN|September 1, 2012
Associations between kidney function and subclinical cardiac abnormalities in CKDMeyeon Park, Chi-yuan Hsu, Yongmei Li, et al.
Diabetes Care|May 23, 2023
Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regressionJosé M Rodriguez-Valadez, Malak Tahsin, Kirsten E Fleischmann, et al.
Journal of the American Heart Association|February 16, 2024
Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta-Regression AnalysisJosé M Rodriguez-Valadez, Malak Tahsin, Umesh Masharani, et al.
BMC Nephrology|August 18, 2019
Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patientsMats C H Lassen, Atif N Qasim, Tor Biering-Sørensen, et al.
JAMA Internal Medicine|June 22, 2026
Apolipoprotein L1 Gene Genotype and Kidney Outcomes After Living Kidney DonationChi-Yuan Hsu, Ying Gao, Barry I Freedman, et al.
Pageof 5